Irving Institute Announces 2019-2020 TL1 Trainees

May 5, 2020

The Irving Institute for Clinical and Translational Research, home to Columbia University’s Clinical and Translational Science Award (CTSA) Program hub, announces the 2019-2020 TL1 pre- and postdoctoral trainees.

The TL1 Program provides doctoral students with one to two years of research training, which run simultaneously with students’ ongoing doctoral training. The program allows doctoral students to gain knowledge and skill-sets that may be outside of their primary academic or clinical discipline. The interdisciplinary education gained as a TL1 trainee will serve as an invaluable asset in conducting future research and collaborating with scientists and investigators from other clinical and academic fields of knowledge. 

Doctoral students awarded this year are:

  • Danielle Baum, BS, Nutritional and Metabolic Biology
  • Ramsey Bekdash, BS, Pharmacology & Molecular Signaling
  • Lia Anna Marina Boyle, BA, Cellular, Molecular and Biophysical Studies
  • Rachel D Field, BS, Biomedical Engineering
  • Sara Gibeley, BS, Nutritional and Metabolic Biology

The TL1 program provides postdoctoral fellows with one to two years of support to participate in an integrated didactic and mentored training program. Postdoctoral candidates dedicate full-time to research and training related to precision medicine. 

Postdoctoral fellows awarded this year are:

  • Andrew S Beenken, MD, PhD, Medicine Nephrology
  • Jennifer Ferris, PhD, Epidemiology
  • Joshua Ethan Motelow, MD, PhD, Pediatrics Critical Care
  • Stacia M Nicholson, PhD, Environmental Health Sciences


Education, Campus, News, Personalized Medicine, Research, NIH/NCATS